m+Medelevator.RU
← Поиск публикаций
ArXiv · 2026

Accelerating scientific discovery with Co-Scientist.

СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Gottweis Juraj, Weng Wei-Hung, Daryin Alexander, Tu Tao, Sirkovic Petar, Myaskovsky Artiom, Glowaty Grzegorz, Weissenberger Felix, Orlandi Alessio, Popovici Dan, Palepu Anil, Rong Keran, Tanno Ryutaro, Saab Khaled, Zhang Fan, Blum Jacob, Carroll Andrew, Kulkarni Kavita, Tomašev Nenad, Zverinski Dina, Rendulic Ivor, Vedadi Elahe, Hasler Florian, Rimanic Luka, Boia Marina, Budiselic Ivan, Feinstein Ben, Bellaiche Mathias, Sheffer Tom, Freyberg Jan, Ratcliff Jeremy, Bertolli Ottavia, Chou Katherine, Hassidim Avinatan, Gokturk Burak, Vahdat Amin, Guan Yuan, Dhillon Vikram, Vaishnav Eeshit Dhaval, Lee Byron, Costa Tiago R D, Penadés José R, Peltz Gary, Matias Yossi, Manyika James, Hassabis Demis, Xu Yunhan, Kohli Pushmeet, Pawlosky Annalisa, Karthikesalingam Alan, Natarajan Vivek

Аннотация

Scientific discovery is driven by scientists generating novel hypotheses for complex problems that undergo rigorous experimental validation. To augment this process, we introduce Co-Scientist, a multi-agent AI system built on Gemini for structured scientific thinking and hypothesis generation. Co-Scientist aims to help scientists discover new original knowledge. Conditioned on their research objectives and prior scientific evidence, it formulates demonstrably novel research hypotheses for experimental verification. The system's design involves agents continuously generating, critiquing and refining hypotheses accelerated by scaling test-time compute. Key contributions include: (1) a multi-agent architecture with an asynchronous task execution framework for flexible compute scaling; (2) a tournament evolution process for self-improving hypotheses generation. Automated evaluations show continued benefits of test-time compute scaling, improving hypothesis quality over time. While general purpose, we focus the validation in three biomedical applications: drug repurposing, novel target discovery 1, and explaining mechanisms of anti-microbial resistance 2. Specifically, Co-Scientist helped identify new drug repurposing candidates and synergistic combination therapies for acute myeloid leukemia, which were validated through in vitro experiments. These real-world validations demonstrate the potential of Co-Scientist to accelerate scientific discovery and usher in an era of AI empowered scientists.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты